AccuLine vs Nucleix
AccuLine vs Nucleix, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AccuLine is on 55/100 and Nucleix on 56/100.
Where each one leads
AccuLine
- agent readiness: 50/100 against 30/100
- headcount growth: +19.0% against +7.1%
Nucleix
- domain rating: 38/100 against 26/100
- headcount: 74 against 11
- funding raised: $102M against $5.5M
- LinkedIn following: 7,846 against 3,578
At a glance
| Measure | AccuLine | Nucleix |
|---|---|---|
| What it is | Developing CORA, a smart exam for early detection of coronary artery disease. | Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis. |
| Category | Healthcare, Biomarkers, Heart, Coronary Artery Disease | Healthcare, Lung, Bladder, Cancer |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2022 | 2008 |
| Headquarters | Not published | Rehovot, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | AccuLine | Nucleix |
|---|---|---|
| Employees | 11 | 74 |
| Headcount growthLast 12 months | +19.0% | +7.1% |
| Total funding | $5.5M | $102M |
| Latest round | Seed | Funding Round |
| LinkedIn followers | 3,578 | 7,846 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AccuLine | Nucleix |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 56/100 |
| Traction | 44/100 | 59/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 33/100 | 36/100 |
| Quality | 58/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 26/100 | 38/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AccuLine | Nucleix |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
What users say
| Measure | AccuLine | Nucleix |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 6 positive, 0 negative across 6 threads |
“Nucleix Demonstrates Potential of its PCR EpiCheck® Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes.”r/LungCancerSupport
AccuLine vs Nucleix: common questions
Which is better, AccuLine or Nucleix?
On our 0-100 score Nucleix rates higher (56/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do AccuLine and Nucleix compare on the numbers?
AccuLine leads on agent readiness (50/100 against 30/100), headcount growth (+19.0% against +7.1%). Nucleix leads on domain rating (38/100 against 26/100), headcount (74 against 11), funding raised ($102M against $5.5M), LinkedIn following (7,846 against 3,578).
What do real users say about AccuLine and Nucleix?
Nucleix: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/LungCancerSupport.
Read the full AccuLine review and pricing or the Nucleix review and pricing. You can also browse other AccuLine alternatives we track.